Micralax citrate / lauryl sulfoacetate rectal cannulas Solution 4

More info

Micralax citrate / lauryl sulfoacetate rectal solution is a prescription without a prescription.

International Pharmacy recommends downloading the prospect of this medicine before use. This leaflet is in Spanish (from Spain).
Micralax CITRATO / LAURYL sulfoacetate 450mg / 45mg rectal solution
Sodium citrate / sodium lauryl sulfoacetate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Follow exactly the instructions of drug administration in this leaflet or as your doctor or pharmacist.
- Keep this leaflet to read it you may have to return to
- If you need more information or advice, consult your pharmacist
- If you experience side effects, consult your doctor or pharmacist, even if it comes to possible side effects not listed in this leaflet.
- You should consult a doctor if worsens or does not improve after 6 days of treatment.

In this leaflet:
1. What is Micralax citrate / lauryl sulfoacetate and what it is used.
2. What you need to know before you start using Micralax citrate / lauryl sulfoacetate.
3. Using Micralax citrate / lauryl sulfoacetate
4. Possible side effects.
5. Conservation Micralax citrate / lauryl sulfoacetate
6. Contents of the pack and other information

1. What is Micralax citrate / lauryl sulfoacetate and what it is used
Micralax citrate / lauryl sulfoacetate acts as a laxative osmotic type, due to the combined action of sodium citrate which acts to retain fluid in the intestine, increasing the volume of water in the stool, and sodium lauryl sulfoacetate, a wetting agent .
It is indicated for the symptomatic local relief of occasional constipation in adults and adolescents over 12 years.
You should consult a doctor if worsens or does not improve after 6 days of treatment.
Authorization holder responsible for marketing and manufacturing:
Headline:
Johnson & Johnson S.A.
Paseo de las Doce Estrellas, 5-7,
28042 Madrid
Responsible for manufacturing:
Famar Orlèans
5, Avenue de Concyr 45071 Orleans Cedex 2 (France)
Responsible for manufacturing:
McNEIL AB
Norrboplatsen, 2
Helsingborg (Sweden)

Date of last revision of this leaflet: 07/2013.
The detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Do you like this product?